Skip to main content
FAQ and Support
Presentations
Full Schedule
Browse By Date
Friday, October 21, 2022
Saturday, October 22, 2022
Sunday, October 23, 2022
Monday, October 24, 2022
Tuesday, October 25, 2022
Wednesday, October 26, 2022
Browse by Course
Browse By Title
Browse By Presenter
Browse by Category
Browse by Oral Abstracts
Browse by Bonus Sessions
Disclosures and Accreditation
ACG 2022 App
Toggle navigation
Home
FAQ and Support
Presentations
Full Schedule
Browse By Date
Friday, October 21, 2022
Saturday, October 22, 2022
Sunday, October 23, 2022
Monday, October 24, 2022
Tuesday, October 25, 2022
Wednesday, October 26, 2022
Browse by Course
Browse By Title
Browse By Presenter
Browse by Category
Browse by Oral Abstracts
Browse by Bonus Sessions
Disclosures and Accreditation
ACG 2022 App
Tweets by ACG 2022 Annual Meeting
Back
Tweet
Ahmed Eltelbany, MD, MPH
Cleveland Clinic
Cleveland, OH
Presentation(s):
68 - Use of GLP1 Agonists or SGLT2 Inhibitors in Non-Alcoholic Steatohepatitis Patients With T2DM Is Associated With a Lower Risk of Cirrhosis: A Nationwide Population-Based Study
Wednesday, October 26, 2022
9:15 AM – 9:30 AM
ET
Email Ahmed